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ABSTRACT 
Objective.  Despite the morbidity and negative outcomes associated with early-onset 
depression, few studies have examined the efficacy of psychosocial treatment for depressive 
disorders during childhood. Integrating family in treatment may have particularly salutary effects 
during this developmental period. This trial compared immediate posttreatment impacts of 
family-focused treatment for childhood depression (FFT-CD) and individual supportive 
psychotherapy (IP) for children aged 7-14 years with depressive disorders.  
Method.  Children were randomized to 15 sessions of FFT-CD (n = 67) or IP (n = 67) over 4 
months. The primary treatment outcome was adequate clinical depression response, defined as 
a ≥50% reduction on the Children’s Depression Rating Scale-Revised (CDRS-R). Additional 
outcomes included patient-centered outcomes (parent- and child-reported treatment 
satisfaction), remission (defined as CDRS-R ≤ 28), change on continuous CDRS-R score, and 
change on child and parent reports of depressive and non-depressive symptoms and social 
adjustment.  
Results.  Significant improvement was evident across groups on depressive and non-
depressive symptoms, global response, and functioning/social adjustment. Compared to 
children randomized to IP, children randomized to FFT-CD showed higher rates of adequate 
clinical depression response (77.7% vs. 59.9%, number needed to treat = 5.72, OR = 2.29, 95% 
CI [1.001, 5.247], t = 1.97, p = .0498).  Across treatments families reported high satisfaction; 
relative to IP families, FFT-CD families reported greater knowledge and skills for managing 
depression. There were no significant differences between treatment arms on secondary 
outcomes.  
Conclusion. Results support the value of psychosocial intervention, underscore the important 
role families play, and highlight the potential for FFT-CD for supporting recovery among children 
suffering from depression.  
Clinical trial registration information—Systems of Support Study for Childhood Depression; 
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http://clinicaltrials.gov/; NCT01159041 
Key words. Childhood depression treatment; family-focused therapy; intervention; 
psychoeducation 
INTRODUCTION 
Approximately 3-4% of preadolescent youths suffer from depressive disorders, and rates 
increase markedly from childhood through adolescence.1 Although less prevalent than in 
adolescence, depression in children is often chronic and severe,2,3 with significant relapse risk 
and poor overall functioning,2,4 bipolar outcome,4 and residual social impairments.5 This high 
morbidity, relapse, and dysfunction may powerfully impede the negotiation of crucial 
developmental tasks.  
Despite significant advances in the treatment of depression in adolescence, few 
approaches, either psychosocial6 or pharmacological,7 have significant empirical support for 
treating children. Results of a recent meta-analysis raised questions regarding the efficacy of 
antidepressant medications over placebo for youths in general,8 and some data suggest 
potentially less efficacy for children compared to adolescents.7 Given the general preference for 
non-medication treatments for children and adolescents with depression and internalizing 
problems,9,10 there is a strong need for effective psychosocial interventions. The few 
randomized clinical trials (RCTs) of psychosocial treatments mostly focus on youths with high 
depressive symptoms.11 One small RCT demonstrated significantly reduced depressive 
symptoms and higher remission rates among youths receiving family-based interpersonal 
psychotherapy for depressive disorders, compared to child-centered supportive therapy,12 
supporting the promise of a family-based approach. 
Family-based interventions may be particularly beneficial during middle to late childhood 
given developmental considerations, including greater dependence on parents and rapidly 
changing cognitive capacity. Younger children are strongly embedded in their family context and 
dependent on parents to provide support and feedback; parents tend to play an active role 
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interfacing with the community to facilitate development (e.g. enrolling youths in 
activities/programs) and modeling/teaching coping and key life skills. These facts underscore 
the need for developmentally-informed treatment during this phase. 
To address the needs of children struggling with depression, we developed a family-focused 
treatment rooted in family and cognitive-behavioral treatment models. As described 
elsewhere,13 our Family-Focused Treatment for Child Depression (FFT-CD) focuses on the 
developmental needs in two major ways. First, throughout FFT-CD, numerous strategies are 
used to enhance family relationships and foster positive, supportive parent–child interactions. 
For example, each session includes regular use of tokens or “family thanks notes” for providing 
positive feedback between members; positive communication skills are directly taught and 
practiced; and children and parents plan and implement enjoyable family activities. Second, 
sessions focus on boosting skills for coping with stress and strengthening emotion regulation 
using techniques such as communication enhancement, problem-solving training, and 
behavioral activation. Throughout treatment, therapists emphasize the developmentally 
appropriate provision of parent support to facilitate enhanced emotion regulation. Although FFT-
CD utilizes many CBT skills-based components, it differs in its strong emphasis on interpersonal 
interactions and relationship enhancement.  
In our Phase 1 trial, children receiving FFT-CD demonstrated significant improvements in 
depressive symptom severity and rates of recovery, with 77% of participants no longer meeting 
criteria for depressive disorder (major depressive disorder [MDD] or dysthymic disorder [DD]) by 
3 months posttreatment.14 Given evidence of safety, feasibility, and benefits, the current two-site 
RCT was developed to rigorously evaluate FFT-CD compared to individual supportive 
psychotherapy (IP). Specific aims were to evaluate: 1) the efficacy of FFT-CD, compared to IP, 
on adequate clinical depression response (primary outcome) at a posttreatment assessment; 
and 2) the impact of FFT-CD, compared to IP, on patient-centered outcomes (parent- and child-
reported satisfaction with and perceived helpfulness of treatment), remission, interviewer-rated 
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depressive symptoms and global functioning, child and parent report of child depressive 
symptoms, child-reported social functioning and anxiety symptoms, and parent-reported 
externalizing and internalizing problems. 
METHOD 
This protocol was registered with clinicaltrials.gov (NCT01159041). Procedures were 
approved by institutional review boards at both sites and monitored by a National Institute of 
Mental Health-designated data safety and monitoring board. Parents gave written informed 
consent, and children gave assent.  
Participant Selection, Recruitment, and Enrollment 
Participants were recruited by advertisement through local parent magazines, radio, print 
and internet; coordination with mental health and pediatric facilities; and outreach to schools 
and parent–teacher associations. Following brief telephone screening, participants were 
evaluated for eligibility and baseline clinical status. Eligibility criteria for youths included: (a) 
diagnosis of current MDD, DD, or depressive disorder-not otherwise specified (DD-NOS); (b) 
age between 7-14; (c) parent/caregiver willing to participate; and (d) willingness to provide 
informed consent (assent). Exclusion criteria were thought or other disturbances that would 
interfere with participation in treatment or assessments (e.g., psychotic disorder, pervasive 
developmental disorder, severe obsessive-compulsive disorder [OCD], active substance 
abuse/dependence, mental retardation), a conduct disorder that threatened the stability of the 
home environment (e.g., recent arrests, juvenile justice, and/or children’s protective service 
involvement), or lacked English fluency.  
Randomization and Blinding   
Eligible participants were randomly assigned in a 1:1 ratio to FFT-CD or IP using a 
computerized algorithm, with assessment staff masked to treatment allocation. A block 
randomization strategy was employed, stratified by site, gender, baseline depression diagnosis 
(syndromal [MDD or DD] vs. subsyndromal [DD-NOS]) and presence vs. absence of 
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antidepressant medication treatment at baseline, with a random mix of blocks of length 2 and 4.   
Treatment Arms. The interventions were to have comparable treatment exposure, with both 
including fifteen 50-60 minute sessions. Because families could not always attend weekly, we 
allowed up to 22 weeks for completion. To minimize the effects of clinician characteristics and 
ensure equivalent levels of therapeutic skill across treatment arms, the same therapists 
administered both interventions. Intensive training, supervision, and monitoring were conducted 
to prevent contamination across treatment arms.    
FFT-CD 
FFT-CD is rooted in cognitive-behavioral and family treatments and designed to assist 
families in developing skills to combat depression and create ways of interacting that protect the 
child from some of the negative sequelae of stress.13 Within a broader psychoeducational 
framework, interpersonal factors impacting the maintenance and treatment of youth depression 
are emphasized, using models demonstrating the interplay of mood and interpersonal 
interactions. Families identify specific “downward and upward spirals” affecting their 
interactions, and learn skills to enhance family functioning and reduce stress, including 
communication enhancement, behavioral activation, and family problem-solving. Handouts 
describe skills to be learned, and role-playing, behavioral rehearsal, and homework 
assignments are used to shape behaviors.    
IP 
IP used Client Centered Therapy, an adaptation of a manualized approach for children 
exposed to trauma,15 that controlled for nonspecific factors, specifically therapist characteristics, 
time, and treatment exposure. IP emphasized individual sessions, with an initial parent session 
and brief, supportive parent meetings every 3-4 weeks. The IP goal was to help children gain 
greater understanding of their emotions through empathic listening; techniques included 
reflecting and clarifying emotions, nondirective problem-solving, positive feedback, and 
exploring and labeling children’s emotional/behavioral reactions. Family sessions and cognitive-
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behavioral techniques (e.g., active modeling, problem-solving training, cognitive restructuring) 
were prohibited.   
Therapist Training and Quality Assurance 
Therapists had at least a master’s degree in psychology or social work and attended or 
observed a two-day workshop for each intervention modality, were certified in each treatment 
model based on tape review of their first two cases, and were supervised weekly (M.C.T. for 
FFT-CD; D.A.L. for IP). Booster trainings occurred at study midpoint.   
Following certification, therapist adherence and competence were evaluated on three 
randomly selected sessions for each case. Adherence refers to the degree to which therapists 
implemented the intervention components specified in the treatment manual; competence refers 
to the skill with which the therapist integrated family concerns during implementation. Given the 
same therapists administered both treatments, it was essential to ensure there was no 
contamination between study arms. Using FFT-CD and IP evaluation measures, we found high 
therapist adherence to and competence in the assigned treatment in both study arms and 
strong differentiation between treatments, suggesting that there were minimal cross-over effects 
(Table 1). On 7-point scales, IP participants received low adherence and competence ratings for 
FFT-CD and high ratings for IP. Conversely, FFT-CD participants received high ratings for FFT-
CD adherence and competence and low ratings for IP adherence ratings. FFT-CD participants 
received high ratings for IP competence, reflecting similar levels of therapist warmth and 
genuineness across treatments.  
Assessments 
Parents and children completed baseline and posttreatment assessments. Raters had at 
least a master’s degree in psychology or social work and were blind to intervention assignment. 
DSM-IV-TR16 diagnoses were based on information from the Schedule for Affective Disorders 
and Schizophrenia for School-Aged Children17 administered to both parents and children. Inter-
rater agreement was excellent for depression diagnoses (MDD, κ = 0.95; any depression 
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diagnosis, κ = 0.91) and major classes of comorbid disorders (κ = 0.76 - 1.00). Depression 
severity over the past two weeks was measured using the interviewer-rated Child Depression 
Rating Scale-Revised (CDRS-R; ICC = 0.94).18 Interviewer-rated overall functioning was 
assessed on the Children's Global Assessment Scale (CGAS; ICC = .77).19  Patient-centered 
outcomes were assessed on parent- and child-rated 5-point scales of overall satisfaction, 
degree of symptoms improvement, family problem improvement, parents feeling capable of 
helping their child, and children feeling capable in solving their problems. Depressive symptoms 
were assessed using the child- and parent-report Child Depression Inventory (CDI).20 Social 
functioning over the past two weeks was indicated on the Social Adjustment Scale for Children - 
Self-Report (SAS-SR)21 and anxiety with the Multidimensional Anxiety Scale for Children.22  
Parent-reported internalizing and externalizing problems were assessed with the Child Behavior 
Checklist.23  
Statistical Analyses. The primary outcome was adequate clinical depression response, 
defined as a 50% reduction in CDRS-R from baseline to posttreatment, consistent with 
adolescent depression treatment trials.6 CDRS-R scores were rescaled to range from 0-90 so 
as not to create an artificial floor for possible percentage reduction. Given that a score of 28 or 
less on the CDRS-R is often used as an indicator of remission in medication trials, we included 
this indicator as a secondary outcome.7 Further, given the lack of treatment trials for youth 12 
years old and younger and the study’s initially proposed sample of 7–12-year-olds (which was 
expanded to aid recruitment), as well as the developmental focus of this treatment on pre-
adolescent youth with depression, we have provided sensitivity analyses focused only on the 7–
12-year-old participants.  Additional secondary outcomes included patient-centered outcomes 
(parent and child satisfaction with treatment), total depressive symptoms (continuous CDRS-R), 
child- and parent-reported depressive symptoms, overall and social functioning, anxiety 
symptoms, and parent-reported internalizing and externalizing problems.   
We compared FFT-CD and IP groups on demographic and clinical characteristics to assess 
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balance across experimental arms at baseline using t-tests for continuous variables and chi-
square for categorical variables. Logistic regression was used to identify factors related to 
treatment dropout and assessment non-response (i.e., lack of posttreatment assessment). 
Treatment effects were evaluated using intent-to-treat (ITT) analyses. We fit a logistic 
regression model for adequate clinical depression response, a dichotomous outcome, with 
treatment arm as the independent variable. Continuous outcomes were assessed using linear 
mixed effects models with treatment group (FFT-CD, IP) as the between-subjects factor, time 
(baseline, posttreatment) as the within-subjects factor, and group-by-time interaction. Site and 
site-by-treatment interactions were included in initial models but were removed from the final 
presented models given their non-significance. To illustrate the magnitude of effects, we present 
proportions, odds ratios (ORs), and number needed to treat (NNT) for binary variables; and 
group means, adjusted average treatment effects, and Cohen’s f2 for continuous variables. 
Results without imputation for missing data were similar to the reported ITT analyses, but 
effects were stronger with the treatment effects for remission significant in completer analyses.   
Multiple imputation by chained equations24 was used to address missing responder and 
remission status for the 13.4% of participants who did not complete the posttreatment 
assessment and missing covariates. Imputations were produced separately by treatment arm to 
avoid biasing treatment-effect estimates. The primary outcome models were run on 5 imputed 
data sets and estimates combined such that standard errors reflect the variability introduced by 
the imputation process.25-27 Variables associated with dropout were included in the imputation 
model and thus not adjusted for in the final analyses. For continuous outcomes, mixed effects 
models automatically handle missing data through likelihood estimation, producing unbiased 
estimates as long as observations are missing at random. Factors associated with non-
response to assessment were thus included as covariates in these models. 
RESULTS 
Participant Disposition and Flow Through the Study 
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As illustrated in the Consolidated Standards of Reporting Clinical Trials diagram 
(CONSORT; Figure 1), of 134 children randomized (n=67 FFT-CD, n=67 IP), 116 (86.6%) 
completed posttreatment assessment, including some treatment dropouts. Across treatment 
arms the number of treatment sessions attended (FFT-CD M = 11.25, SD = 4.97; IP Mean = 
11.78, SD = 4.64; t(132) = -0.59, p = .55) and rates of treatment dropout were comparable (OR 
= 1.26, p = .56) with 14.2% of participants classified as early treatment dropouts (0-4 sessions: 
FFT-CD n = 10, 14.9%; IP n = 9, 13.4%), 11.9% as mid-treatment dropouts (5-9 sessions: FFT-
CD n = 9, 13.4%; IP n = 7, 10.5%) and 73.9% as treatment completers (10-15: FFT-CD n = 48, 
71.7%; IP n = 51, 76.1%). Assessment non-response was more common among FFT-CD 
versus IP youths (OR = 2.99, p = .05). Treatment dropout and assessment non-response at 
posttreatment were associated with non-white race (OR = 3.71, p = .002; OR = 3.14, p = .03, 
respectively), one-parent family composition (OR = 3.00, p = .007; OR = 3.52, p = .02 
respectively), lower income (OR = 0.62, p = .002; OR = 0.68, p = .04 respectively), and overall 
lower depression severity on the pretreatment CDRS-R (OR = 0.96, p = .04; OR = 0.95, p = .06 
respectively).  
Demographic and Clinical Characteristics Across Treatment Groups 
Referrals included 47 (35%) from clinical settings, 59 (44%) from advertising, 14 (10.5%) 
from schools, and 14 (10.5%) from other sources. Treatment groups did not differ on baseline 
clinical and demographic variables. Table 2 shows the baseline demographic and clinical 
characteristics; Table 3 displays the means and standard deviations for the continuous 
outcomes at baseline and follow-up. The sample was 56% female, had a mean age of almost 
11 years, included diverse racial/ethnic groups, and had median income in the $50,000 - 
$74,999 range (approximately 36% of families reported an income below $50,000, and 45% 
reported an income above $75,000). Approximately 60% of youths were living with two parents.  
Major depressive disorder was the predominant diagnosis (71%), and comorbidity was 
common. Antidepressant medication usage was uncommon (10%), but prior outpatient and 
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school-based treatment was common. 
Primary Clinical Outcome 
As illustrated in Table 4, ITT analyses indicated a statistically significant group effect for 
adequate clinical depression response based on a CDRS-R reduction of ≥ 50%, with those 
randomized to FFT-CD more likely to show this response than those randomized to IP (77.7% 
vs. 59.9%, NNT = 5.72, OR = 2.291, 95% CI [1.001, 5.247], t = 1.97, p = .0498). The ITT model 
with imputation was consistent with the complete data model (79.6% FFT vs. 59.7% IP, NNT = 
5.0, OR = 2.64, 95% CI [1.15, 6.08], χ2 = 5.37, df = 1, p = .0205). As noted in Table 4, the group 
difference in remission did not rise to the level of statistical significance (p = .1043) in ITT 
analyses. However, in the model using complete data, FFT-CD children had significantly higher 
rates of remission compared to IP children (53.7% FFT vs. 35.5% IP, NNT = 5.5, OR = 2.11, 
95% CI [1.001, 4.448], χ2 = 3.89, df = 1, p = .0486). There were no statistically significant 
differences between the two intervention conditions within the 7–12-year-old subsample in ITT 
analyses. However, as with the full sample, the results were strongest for adequate clinical 
depression response, which showed a trend-level treatment effect in the ITT analyses (p = 
.0895) and a significant effect favoring FFT-CD in the completer analyses (84.6% FFT vs. 
64.4% IP, NNT = 4.96, OR = 3.03, 95% CI [1.049, 8.782], χ2 =4.40, df = 1, p =.0360).  
Patient-centered outcomes included overall treatment satisfaction and satisfaction on 
specific domains targeted in FFT-CD (e.g., parental understanding of how to help their child, 
child belief that treatment helped them get along better with their family). Similar overall 
satisfaction was reported across conditions (Table 5), with most parents and children “strongly 
agreeing” that they were satisfied with treatment. Compared with IP parents, FFT-CD parents 
agreed more with statements that treatment helped them understand a) how to manage their 
child’s depression and b) what to do/not do to help their child. FFT-CD children agreed more 
with the statement that attending sessions helped them get along better with their family, 
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relative to IP children.  
Secondary Continuous Outcomes 
Raw data on continuous outcomes, pre- and posttreatment, are included in Table 3. As 
illustrated in Table 6, after adjusting for race, income, and family composition, there was a 
significant time effect on all measures, with children showing improvement from baseline to 
posttreatment on depression severity (CDRS-R, CDI), functioning (CGAS, SAS-SR), and 
comorbid symptoms (MASC, CBCL Internalizing and Externalizing); however, there were no 
treatment group nor treatment group-by-time interaction effects.  
Predictors and Moderators of Treatment Outcome 
We examined demographic (age group, gender, race, family composition, family income) 
and clinical variables (syndromal versus subsyndromal depression, baseline CDRS score, 
comorbid anxiety disorder, comorbid disruptive behavior disorder, chronicity, current 
antidepressant medication) as potential predictors and moderators of treatment response but 
found no significant effects. 
DISCUSSION 
This study reports immediate posttreatment data from an RCT comparing FFT-CD to IP for 
the treatment of depressive disorders in 7–14-year-olds – the largest study to date to evaluate a 
psychosocial treatment specifically designed for children with primary depressive disorders. 
Major findings were: 1) FFT-CD was associated with increased likelihood of an adequate 
depression clinical response (reduction in CDRS-R score ≥ 50%), compared to IP, with the NNT 
estimate suggesting that treating roughly 5.72 children with FFT-CD would lead to one 
additional positive treatment response as compared to IP; 2) both FFT-CD and IP led to 
improvements, with 77.7% responding to FFT-CD and 59.9% to IP; 3) parent and child 
satisfaction was high for both treatments, but FFT-CD recipients reported being better able to 
manage depression and associated problems; and 4) across treatments, improvements over 
time were observed across measures of depression, functioning/social adjustment, and non-
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depressive symptoms. 
The finding that children improved over time is consistent with the literature indicating that 
depressive disorders in children tend to resolve with time and diverse treatment approaches 
yield benefits – the so-called dodo bird verdict (“all have won and all shall have prizes”).28 
Consistent with study hypotheses, FFT-CD was associated with greater depression clinical 
response than individual supportive therapy and greater remission rates in completer analyses. 
These results are consistent with Dietz et al.12 showing the superiority of family-based 
interpersonal therapy compared to individual client-centered therapy, and other studies 
supporting benefits of family treatments for childhood mood disorders29 and other child30,31 as 
well as adolescent disorders.32,33 This advantage for FFT-CD is noteworthy given that IP was an 
active treatment condition and that child and parent satisfaction was high and similar across 
conditions.  
Although effects were in the expected direction, treatment groups did not differ significantly 
on the other secondary outcomes. This is likely a function of several factors. First, lack of 
differences on continuous measures may reflect unexplained variability that was eliminated 
when dichotomizing the primary outcome. Second, the sample reflected the frequent 
heterogeneity typical of youth depression, and non-specific effects of IP had potent impact 
across a range of variables. Third, although the study was powered for medium effect sizes, 
effects may have been smaller for secondary and exploratory outcomes. Finally, analyses of 
later outcomes may be important for clarifying the value of FFT-CD relative to other treatments 
on a range of measures, as other studies of FFT in bipolar illness have found the advantages of 
FFT to be stronger at later follow-up points.34,35 
Satisfaction and adherence data reflect strong parent and child alliances and that, across 
conditions, therapists were able to build rapport and foster therapeutic relationships – important 
non-specific treatment factors. When asked how much treatment helped them positively interact 
as a family, FFT-CD parents and children were more likely to endorse greater understanding 
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and improved behaviors in response to treatment, suggesting perceived changes in the target 
mechanisms of FFT-CD. 
 Methodological strengths included full, reliable diagnostic evaluation at all time points with 
blind assessment by independent evaluators; equivalence of groups across baseline 
demographic and clinical characteristics; an active comparison condition controlling for non-
specific treatment factors (e.g., therapist factors, time, dose); and clear differentiation between 
treatment arms. The study also has limitations. First, lacking an inactive control group, we 
cannot determine the degree to which improvement might be attributed to the tendency for 
depressive disorders to remit over time, although the average length of depressive episodes in 
children in clinical settings may typically be 7-9 months,2 suggesting both study treatments may 
have accelerated recovery. Given the deleterious impact of youth depressive disorders, it was 
unethical to include an untreated group. Second, although the treatment model was originally 
designed for children ages 7-12,14 because of the low rate of depressive disorders in 
preadolescents and the impact of this age effect on recruitment, we expanded to an upper age 
limit of 14 years. FFT-CD may be particularly beneficial during childhood but comparable to IP 
as youths enter adolescence. This study was underpowered to detect treatment group-by-age 
interactions or other moderation effects. Third, the same therapists provided both FFT-CD and 
IP. Although this strategy ensured both treatments were delivered with similarly high levels of 
therapeutic skill and minimized clinician differences across treatments, it introduced the 
possibility for cross-over effects between conditions and therapist allegiance to one condition. 
However, fidelity ratings included consideration of therapists’ use of treatment-specific 
interventions (prescribed) as well as non-use of alternative intervention strategies (proscribed); 
high adherence to both treatments provides strong evidence that there was little contamination 
across modalities. Additionally, high competence ratings in both arms suggest that, despite any 
potential therapist allegiances, they delivered both interventions well.   
Overall, our findings underscore the value of psychosocial interventions in the treatment 
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of depressive disorders in childhood. The high rate of response to IP may be a function of 
nonspecific factors, as well as the passage of time,28 and is consistent with other studies that 
employed this client-centered approach.15 During this period of development, a strategy that 
formally integrates the family within treatment and provides specific and tailored skills/strategies 
for managing stress may have some advantage over a less structured, supportive approach.  
FFT-CD with its strong emphasis on enhancing family strengths and coping may provide an 
ideal approach during this developmental period.    
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Table 1.  Treatment Adherence/Competence 
Type of Treatment FFT-CD Mean (SD) 
IP 
Mean (SD) 
FFT-CD 
  
Competence in FFT-CD 6.43 (1.10) 1.75 (1.26) 
Adherence to FFT-CD 6.34 (1.44) 1.07 (0.26) 
IP   
Competence in IP 6.95 (0.17) 7.00 (0) 
Adherence to IP 1.03 (0.25) 6.57 (1.38) 
Note:  All scales were rated from (1) not at all competent/adherent to (7) extremely competent/adherent. 
FFT-CD = Family-Focused Treatment for Childhood Depression; IP = Individual Psychotherapy.   
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Table 2. Sample Characteristics  
 
Total 
 (n = 134) 
FFT-CD  
(n = 67) 
IP                        
(n = 67) 
p-value 
Child Age Mean (SD) 
Child Age Group, n(%) 
10.84 (2.09) 10.73 (2.10) 10.96 (2.09) .54 
.84 
  Childhood (ages 7-12) 
  Early adolescent (13-14) 
99 (74) 
35 (26) 
50 (75) 
17 (25) 
49 (73) 
18 (27) 
 
Child Gender, n(%)  
  Female  
  Male 
 
75 (56) 
59 (44) 
 
37 (55) 
30 (45) 
 
38 (57) 
29 (43) 
.86 
Child Race/Ethnicity, n(%) 
  Caucasian 
  Latino/Hispanic 
  African-American 
  Other 
 
68 (51) 
20 (15) 
35 (26) 
11 (8) 
 
37 (55) 
10 (15) 
14 (21) 
6 (9) 
 
31 (46) 
10 (15) 
21 (31) 
5 (8) 
.57 
Family Composition, n(%) 
  Two parents  
  One parent/guardian 
 
80 (60) 
54 (40) 
 
43 (64) 
24 (36) 
 
37 (55) 
30 (45) 
.31 
Family Income Mean (SD) 3.84 (1.31) 3.95 (1.26) 3.72 (1.36) .31 
Child Depression Diagnosis, n(%) 
  Major depression 
  Dysthymic disorder  
  Double depression  
  Depressive disorder NOS 
 
89 (66) 
24 (18) 
7 (5) 
14 (11) 
 
43 (64) 
12 (18) 
3 (4) 
9 (14) 
 
46 (69) 
12 (18) 
4 (5) 
5 (8) 
.71 
Diagnostic Comorbidity, n(%)  
     Anxiety disorders  
     Disruptive behavior disorder 
 
50 (37) 
56 (42) 
 
21 (31) 
24 (36) 
 
29 (43) 
32 (48) 
 
.15 
.16 
Note: Income ranges from 1 (< $14,000 annually) to 5 (> $75,000 annually). “Disruptive behavior 
disorder” includes attention-deficit/hyperactivity disorder, oppositional defiant disorder, and conduct 
disorders. Treatment Service History: Individuals may be in multiple categories. “Intensive” describes 
inpatient, partial hospitalization or day treatment; “outpatient” describes therapy and crisis services; 
“school-based” describes special class or school, counselor, or psychologist or other mental health 
service; “medical” describes physician or ER visits; “other” describes religious or holistic practitioners; 
“medication other” describes guanfacine, divalproex sodium, aripiprazole, clonidine, clonazepam. FFT-
CD = family-focused treatment for childhood depression; IP = individual psychotherapy; NOS = not 
otherwise specified.  
Treatment Utilization  
    
  Medication – Current, n(%) 
     Any 
     Antidepressant 
     Stimulant 
     Other 
 
32 (24) 
15 (10) 
14 (10) 
10 (7) 
 
14 (21) 
6 (9) 
6 (9) 
7 (10) 
 
17 (26) 
9 (13) 
8 (12) 
3 (4) 
 
.54 
.41 
.57 
.19 
  Treatment Service History, n(%)  
     Intensive 
     Outpatient 
     School-based 
     Medical 
     Other  
 
6 (4) 
55 (41) 
71 (53) 
42 (31) 
10 (7) 
 
3 (4) 
27 (40) 
33 (49) 
23 (34) 
6 (9) 
 
3 (4) 
28 (42) 
38 (57) 
19 (28) 
4 (6) 
 
.95 
.74 
.28 
.49 
.54 
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Table 3. Pre- and Posttreatment Descriptive Statistics, by Condition 
 Pretreatment Posttreatment 
Variable FFT-CD IP FFT-CD IP Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Depressive Symptoms 
    
CDRS-R 53.07 (10.42) 54.10 (12.31) 30.85 (11.31) 34.42 (12.48) 
CDI - CR 15.57 (11.11) 15.11 (10.44) 7.30 (8.99) 9.72 (8.14) 
CDI - PR 26.33 (7.54) 26.78 (7.42) 16.22 (7.83) 17.82 (8.68) 
Functioning 
    
CGAS 53.15 (5.89) 53.96 (6.04) 63.70 (9.61) 64.65 (10.74) 
SAS-CR 50.09 (15.18) 50.85 (15.05) 42.09 (12.50) 45.68 (12.21) 
Comorbid Problems 
    
MASC-CR 50.75 (20.92) 54.42 (17.87) 47.17 (21.93) 49.70 (19.51) 
CBC-IP 69.78 (7.93) 70.35 (9.87) 59.77 (11.98) 61.63 (10.60) 
CBC-EP 61.57 (8.45) 60.67 (10.13) 54.77 (10.91) 56.57 (9.45) 
Note: CBC-EP = Child Behavior Checklist – Externalizing Problems; CBC-IP = Child Behavior Checklist – 
Internalizing Problems; CDI = Children’s Depression Inventory; CDRS-R = Children’s Depression Rating 
Scale - Revised; CGAS = Children’s Global Assessment Scale; CR = child report; FFT-CD = family-focused 
treatment for childhood depression; IP = individual psychotherapy; MASC-CR = Multidimensional Anxiety 
Scale for Children – Child Report; PR = parent report; SAS-CR = Social Adjustment Scale – Child Report. 
 
Table 4: Clinical Outcome by Treatment Group With Intent to Treat and Completer Analyses 
 Intent-to-Treat Completer 
 FFT-CD % IP % OR NNT FFT-CD % IP % OR NNT 
Full Sample n = 67 n = 67   n = 54 n = 62   
Adequate clinical 
depression response, 
CDRS-R ≥ 50%a 
77.4% 59.9% 2.29 5.72 79.6% 59.7% 2.64 5.01 
Remission,  
CDRS ≤ 28b 52.3% 37.3% 1.84 6.70 53.7% 35.5% 2.11 5.50 
7–12-year-old children 
only n = 50 n = 49   n = 39 n = 45  
 
Adequate clinical 
depression response, 
CDRS-R ≥ 50%c 
81.9% 64.6% 2.48 5.78 84.6% 64.4% 3.03 4.96 
Remission,  
CDRS ≤ 28d 52.7% 41.9% 1.54 9.27 53.9% 40.0% 1.75 7.22 
Note:  Completer includes those with posttreatment assessment data regardless of treatment participation. 
CDRS (-R) = Children’s Depression Rating Scale (-Revised); FFT-CD = family-focused treatment for 
childhood depression; IP = individual psychotherapy; NNT = number needed to treat; OR = odds ratio.  
a ITT t  = 1.97, p = .0498; Completer χ2 = 5.37, df = 1, p = .0205 
b ITT t = 1.63, p = .1043; Completer χ2 = 3.89, df = 1, p = .0486 
c ITT t = 1.72, p = .0895; Completer χ2 = 4.40, df = 1, p = .0360 
d ITT t = 0.99, p = .3200; Completer χ2 = 1.61, df = 1, p = .2044 
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Table 5.  Patient-Centered Outcomes 
 
Variable 
FFT-CD IP 
t-value df p-value d 
Mean (SD) Mean (SD) 
Parent Report 
      
Overall satisfaction 1.62 (0.87) 1.52 (0.91) -0.560 101.00 .58 -0.11 
Attending sessions helped me 
understand how to manage my 
child’s depression 
1.96 (0.95) 2.51 (1.17) 2.63 98.74 .01 0.52 
Attending sessions helped me 
understand how to help my child 
at home 
1.72 (0.88) 2.43 (1.19) 3.48 95.89 <.001 0.68 
Child Report 
      
Overall satisfaction 1.79 (0.94) 1.80 (1.21) 0.04 96.00 .97 0.01 
Attending sessions helped me 
get along better with my family  1.80 (1.03) 2.26 (1.20) 2.12 105.00 .04 0.41 
Attending sessions helped me 
deal with problems  1.74 (0.88) 2.18 (1.38) 1.98 92.63 .05 0.39 
Note:  Scales were rated from (1) strongly agree to (5) strongly disagree. FFT-CD = family-
focused treatment for childhood depression; IP = individual psychotherapy. 
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Table 6.  Change From Baseline to Posttreatment on Secondary Outcomes 
 Group Time Group x Time Estimated Tx Effect 
 F p-value F p-value F p-value Beta f2 
Depressive Symptoms 
        
CDRS-R 0.37 .54 397.68 <.0001 2.02 .16 -2.99 .018 
CDI-CR 0.00 .97 58.02 <.0001 2.65 .11 -2.82 .025 
CDI-PR 0.58 .45 161.79 <.0001 0.21 .65 -0.69 .002 
Functioning  
        
CGAS 1.52 .22 144.30 <.0001 0.11 .74 -0.59 .0001 
SAS-SR 0.14 .71 32.08 <.0001 0.90 .34 -2.15 .008 
Comorbid Problems 
        
Multidimensional Anxiety Scale for Children 0.23 .63 5.85 .017 0.32 .58 1.69 .003 
CBCL Externalizing Problems 0.08 .78 62.04 <.0001 1.26 .26 -1.62 .013 
CBCL Internalizing Problems 0.66 .42 152.30 <.0001 0.67 .41 -1.23 .007 
Note:  Estimated treatment effects correspond to the group by time interaction coefficient in the mixed models, which gives the 
difference in change scores for the family-focused treatment for childhood depression (FFT-CD) and individual psychotherapy (IP) 
groups, adjusted for race, income, and family composition. Cohen’s f2 is the standard effect size for regression models, based on 
variance explained; values of .02, .15, and .35 are small, medium, and large, respectively. CBCL = Child Behavior Checklist; CDI = 
Child Depression Inventory; CDRS-R = Child Depression Rating Scale-Revised; CGAS = Children’s Global Assessment Scale; CR = 
child report; PR = parent report; SAS-SR = Social Adjustment Scale-Self Report; Tx = treatment.  
Figure 1. Participant flow across the study. Note: FFT = family-focused treatment; IP = individual psychotherapy. 

